Botulinum Toxin Type A (BOTOX®) Treatment of Masseter Muscle Hypertrophy
Study Identifier
191622-130
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete
Results Available
Protocol
Available Language(s): English
Statistical Analysis Plan
Available Language(s): English
Study Details
Medical Condition
Study Drug
Phase
Phase 2
Sex
Female & Male
Age
18 - 50 Years
Protocol Summary
This study will evaluate the safety and efficacy of a range of doses of botulinum toxin Type A (BOTOX®) for the treatment of patients with bilateral Masseter Muscle Hypertrophy (MMH).
Study Locations
Location
Status
Location
Shape Clinic
Darlinghurst, New South Wales, Australia, 2010
Status
Not applicable
Location
Central Sydney Dermatology
Sydney, New South Wales, Australia, 2000
Status
Not applicable
Location
Esteem Beauty & Day Spa
Main Beach, Queensland, Australia, 4217
Status
Not applicable
Location
The Rose Medical & Aesthetic Centre
North Fremantle, Western Australia, Australia, 6159
Status
Not applicable
Location
Dr. Jean Carruthers Cosmetic Surgery, Inc.
Vancouver, British Columbia, Canada, V5Z 4E1
Status
Not applicable
Location
Dr. Shannon Humphrey Inc.
Vancouver, British Columbia, Canada, V5Z 4E1
Status
Not applicable
Showing {first} - {last} of {total} Results